PUBLISHER: IMARC | PRODUCT CODE: 1423209
PUBLISHER: IMARC | PRODUCT CODE: 1423209
Cardiac Biomarkers Market Report by Type (Troponins, Myocardial Muscle Creatine Kinase, Myoglobin, Brain Natriuretic Peptide or NT-proBNP, Ischemia Modified Albumin, and Others), Location of Testing, Application, and Region 2024-2032
Abstract
The global cardiac biomarkers market size reached US$ 10.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 21.0 Billion by 2032, exhibiting a growth rate (CAGR) of 7.6% during 2024-2032.
Cardiac markers, also known as cardiac biomarkers, are released into the bloodstream when the heart is stressed, or its muscles are damaged. These markers include different types of enzymes, hormones, and proteins, such as cardiac troponins, creatine kinase (CK), ischemia-modified albumin (IMA), and myoglobin. Measurement and testing of these markers can help in diagnosing heart conditions like cardiac ischemia and acute coronary syndrome (ACS). At present, the triage and diagnostic systems used for determining the risk of these conditions are based on electrocardiograms (ECGs) and clinical history. However, these systems are insufficient and can lead to misdiagnosis or delay in treatment. As cardiac marker testing offers higher accuracy and can identify the conditions in the early stages of presentation, they are gaining traction across the globe. These markers can also help in monitoring the prognosis of these condition with greater accuracy and providing the most effective treatment to the patients.
Global Cardiac Biomarkers Market Drivers:
Over the past few years, there has been a rise in the number of patients suffering from ACS which has created a demand for cardiac marker testing at a global level. Other than this, rising awareness among patients and healthcare providers about the importance of early diagnosis of various CVDs is driving the demand for these markers. In addition, there are numerous private and public organizations which are investing in R&D activities to develop advanced technologies in the field of cardiac biomarkers. For instance, blood tests for high-sensitivity cardiac troponin I have been demonstrated to identify patients who are at a higher risk of a second heart attack. Moreover, high accuracy and rapid results offered by biomarker testing, coupled with the availability of affordable cardiac point-of-care testing, are some of the other factors which are contributing to the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global cardiac biomarkers market report, along with forecasts at the global and regional level from 2024-2032. Our report has categorized the market based on type, location of testing, and application.
Breakup by Type:
Troponins (T and I)
Myocardial Muscle Creatine Kinase (CK-MB)
Myoglobin
Brain Natriuretic Peptide (BNPs) or NT-proBNP
Ischemia Modified Albumin (IMA)
Others
Based on the type, the market has been segmented into troponins (T and I), myocardial muscle creatine kinase (CK-MB), myoglobin, brain natriuretic peptide (BNPs) or NT-proBNP, ischemia modified albumin (IMA) and others.
Breakup by Location of Testing:
Laboratory Testing
Point of Care Testing
Based on the location of testing, the market has been segmented into laboratory testing and point of care testing. Laboratory testing currently accounts for a larger share.
Breakup by Application:
Myocardial Infarction
Congestive Heart Failure
Acute Coronary Syndrome
Atherosclerosis
Others
Based on the application, the market has been segmented into myocardial infarction, congestive heart failure, acute coronary syndrome, atherosclerosis and others. Myocardial infarction currently accounts for the highest share.
Regional Insights:
North America
Asia Pacific
Europe
Middle East and Africa
Latin America
Region-wise, the market has been segmented into North America, Asia Pacific, Europe, Middle East and Africa, and Latin America. Amongst these, North America is the biggest market, accounting for majority of the global share.
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Abbott Laboratories, Alere Inc., Beckman Coulter, Becton, Dickinson And Co., Biomerieux, Bio-Rad Laboratories, Randox Laboratories, Roche Diagnostics Corporation, Siemens Healthcare and Thermo Fisher Scientific.
Key Questions Answered in This Report
- 1. What was the size of the global cardiac biomarkers market in 2023?
- 2. What is the expected growth rate of the global cardiac biomarkers market during 2024-2032?
- 3. What are the key factors driving the global cardiac biomarkers market?
- 4. What has been the impact of COVID-19 on the global cardiac biomarkers market?
- 5. What is the breakup of the global cardiac biomarkers market based on the location of testing?
- 6. What is the breakup of the global cardiac biomarkers market based on the application?
- 7. What are the key regions in the global cardiac biomarkers market?
- 8. Who are the key companies/players in the global cardiac biomarkers market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
- 4.1 Overview
- 4.2 Key Industry Trends
5 Global Cardiac Biomarkers Market
- 5.1 Market Overview
- 5.2 Market Performance
- 5.3 Impact of COVID-19
- 5.4 Market Breakup by Type
- 5.5 Market Breakup by Location of Testing
- 5.6 Market Breakup by Application
- 5.7 Market Breakup by Region
- 5.8 Market Forecast
6 Market Breakup by Type
- 6.1 Troponins (T and I)
- 6.1.1 Market Trends
- 6.1.2 Market Forecast
- 6.2 Myocardial Muscle Creatine Kinase (CK-MB)
- 6.2.1 Market Trends
- 6.2.2 Market Forecast
- 6.3 Myoglobin
- 6.3.1 Market Trends
- 6.3.2 Market Forecast
- 6.4 Brain Natriuretic Peptide (BNPs) or NT-proBNP
- 6.4.1 Market Trends
- 6.4.2 Market Forecast
- 6.5 Ischemia Modified Albumin (IMA)
- 6.5.1 Market Trends
- 6.5.2 Market Forecast
- 6.6 Others
- 6.6.1 Market Trends
- 6.6.2 Market Forecast
7 Market Breakup by Location of Testing
- 7.1 Laboratory Testing
- 7.1.1 Market Trends
- 7.1.2 Market Forecast
- 7.2 Point of Care Testing
- 7.2.1 Market Trends
- 7.2.2 Market Forecast
8 Market Breakup by Application
- 8.1 Myocardial Infarction
- 8.1.1 Market Trends
- 8.1.2 Market Forecast
- 8.2 Congestive Heart Failure
- 8.2.1 Market Trends
- 8.2.2 Market Forecast
- 8.3 Acute Coronary Syndrome
- 8.3.1 Market Trends
- 8.3.2 Market Forecast
- 8.4 Atherosclerosis
- 8.4.1 Market Trends
- 8.4.2 Market Forecast
- 8.5 Others
- 8.5.1 Market Trends
- 8.5.2 Market Forecast
9 Market Breakup by Region
- 9.1 North America
- 9.1.1 Market Trends
- 9.1.2 Market Forecast
- 9.2 Asia Pacific
- 9.2.1 Market Trends
- 9.2.2 Market Forecast
- 9.3 Europe
- 9.3.1 Market Trends
- 9.3.2 Market Forecast
- 9.4 Middle East and Africa
- 9.4.1 Market Trends
- 9.4.2 Market Forecast
- 9.5 Latin America
- 9.5.1 Market Trends
- 9.5.2 Market Forecast
10 Global Cardiac Biomarkers Industry: SWOT Analysis
- 10.1 Overview
- 10.2 Strengths
- 10.3 Weaknesses
- 10.4 Opportunities
- 10.5 Threats
11 Global Cardiac Biomarkers Industry: Value Chain Analysis
12 Global Cardiac Biomarkers Industry: Porters Five Forces Analysis
- 12.1 Overview
- 12.2 Bargaining Power of Buyers
- 12.3 Bargaining Power of Suppliers
- 12.4 Degree of Competition
- 12.5 Threat of New Entrants
- 12.6 Threat of Substitutes
13 Global Cardiac Biomarkers Industry: Price Analysis
14 Competitive Landscape
- 14.1 Market Structure
- 14.2 Key Players
- 14.3 Profiles of Key Players
- 14.3.1 Abbott Laboratories
- 14.3.2 Alere Inc.
- 14.3.3 Beckman Coulter
- 14.3.4 Becton, Dickinson And Co.
- 14.3.5 Biomerieux
- 14.3.6 Bio-Rad Laboratories
- 14.3.7 Randox Laboratories
- 14.3.8 Roche Diagnostics Corporation
- 14.3.9 Siemens Healthcare
- 14.3.10 Thermo Fisher Scientific
List of Figures
- Figure 1: Global: Cardiac Biomarkers Market: Major Drivers and Challenges
- Figure 2: Global: Cardiac Biomarkers Market: Sales Value (in Billion US$), 2018-2023
- Figure 3: Global: Cardiac Biomarkers Market: Breakup by Type (in %), 2023
- Figure 4: Global: Cardiac Biomarkers Market: Breakup by Location of Testing (in %), 2023
- Figure 5: Global: Cardiac Biomarkers Market: Breakup by Application (in %), 2023
- Figure 6: Global: Cardiac Biomarkers Market: Breakup by Region (in %), 2023
- Figure 7: Global: Cardiac Biomarkers Market Forecast: Sales Value (in Billion US$), 2024-2032
- Figure 8: Global: Cardiac Biomarkers Industry: SWOT Analysis
- Figure 9: Global: Cardiac Biomarkers Industry: Value Chain Analysis
- Figure 10: Global: Cardiac Biomarkers Industry: Porter's Five Forces Analysis
- Figure 11: Global: Cardiac Biomarkers (Troponins) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 12: Global: Cardiac Biomarkers (Troponins) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 13: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 14: Global: Cardiac Biomarkers (Myocardial Muscle Creatine Kinase) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 15: Global: Cardiac Biomarkers (Myoglobin) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 16: Global: Cardiac Biomarkers (Myoglobin) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 17: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 18: Global: Cardiac Biomarkers (Brain Natriuretic Peptide) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 19: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 20: Global: Cardiac Biomarkers (Ischemia Modified Albumin) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 21: Global: Cardiac Biomarkers (Other Types) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 22: Global: Cardiac Biomarkers (Other Types) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 23: Global: Cardiac Biomarkers (Laboratory Testing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 24: Global: Cardiac Biomarkers (Laboratory Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 25: Global: Cardiac Biomarkers (Point of Care Testing) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 26: Global: Cardiac Biomarkers (Point of Care Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 27: Global: Cardiac Biomarkers (Myocardial Infarction) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 28: Global: Cardiac Biomarkers (Myocardial Infarction) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 29: Global: Cardiac Biomarkers (Congestive Heart Failure) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 30: Global: Cardiac Biomarkers (Congestive Heart Failure) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 31: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 32: Global: Cardiac Biomarkers (Acute Coronary Syndrome) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 33: Global: Cardiac Biomarkers (Atherosclerosis) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 34: Global: Cardiac Biomarkers (Atherosclerosis) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 35: Global: Cardiac Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
- Figure 36: Global: Cardiac Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 37: North America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 38: North America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 39: Asia Pacific: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 40: Asia Pacific: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 41: Europe: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 42: Europe: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 43: Middle East and Africa: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 44: Middle East and Africa: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
- Figure 45: Latin America: Cardiac Biomarkers Market: Sales Value (in Million US$), 2018 & 2023
- Figure 46: Latin America: Cardiac Biomarkers Market Forecast: Sales Value (in Million US$), 2024-2032
List of Tables
- Table 1: Global: Cardiac Biomarkers Market: Key Industry Highlights, 2023 and 2032
- Table 2: Global: Cardiac Biomarkers Market Forecast: Breakup by Type (in Million US$), 2024-2032
- Table 3: Global: Cardiac Biomarkers Market Forecast: Breakup by Location of Testing (in Million US$), 2024-2032
- Table 4: Global: Cardiac Biomarkers Market Forecast: Breakup by Application (in Million US$), 2024-2032
- Table 5: Global: Cardiac Biomarkers Market Forecast: Breakup by Region (in Million US$), 2024-2032
- Table 6: Global: Cardiac Biomarkers Market Structure
- Table 7: Global: Cardiac Biomarkers Market: Key Players
